BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Correale M, Paolillo S, Mercurio V, Limongelli G, Barillà F, Ruocco G, Palazzuoli A, Scrutinio D, Lagioia R, Lombardi C, Lupi L, Magrì D, Masarone D, Pacileo G, Scicchitano P, Matteo Ciccone M, Parati G, Tocchetti CG, Nodari S. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure. European Journal of Internal Medicine 2020;71:23-31. [DOI: 10.1016/j.ejim.2019.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M, Brunetti ND. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic. Cardiovasc Drugs Ther 2021. [PMID: 34328581 DOI: 10.1007/s10557-021-07217-8] [Reference Citation Analysis]
2 Correale M, Leopizzi A, Mallardi A, Ranieri A, Suriano MP, D'Alessandro D, Tricarico L, Mazzeo P, Tucci S, Pastore G, Maulucci G, Di Biase M, Brunetti ND. Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation. Thromb Res 2020;195:16-20. [PMID: 32634728 DOI: 10.1016/j.thromres.2020.06.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Paolillo S, Ruocco G, Filardi PP, Palazzuoli A, Tocchetti CG, Nodari S, Lombardi C, Metra M, Correale M; “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology. Direct oral anticoagulants across the heart failure spectrum: the precision medicine era. Heart Fail Rev 2020. [PMID: 32583229 DOI: 10.1007/s10741-020-09994-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Malavasi VL, Valenti AC, Ruggerini S, Manicardi M, Orlandi C, Sgreccia D, Vitolo M, Proietti M, Lip GYH, Boriani G. Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome. J Clin Med 2022;11:891. [PMID: 35160341 DOI: 10.3390/jcm11030891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Paolillo S, Scardovi AB, Campodonico J. Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation. Eur J Prev Cardiol 2020;27:27-34. [PMID: 33238738 DOI: 10.1177/2047487320960288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Masarone D, Martucci ML, Errigo V, Pacileo G. The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction. J Cardiovasc Dev Dis 2021;8:101. [PMID: 34564119 DOI: 10.3390/jcdd8090101] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Makhija RR, Mukherjee D. Endovascular therapies for Type B Aortic Dissection. Cardiovasc Hematol Disord Drug Targets 2021. [PMID: 34565325 DOI: 10.2174/1871529X21666210924141446] [Reference Citation Analysis]
8 Correale M, Lamacchia O, Ciccarelli M, Dattilo G, Tricarico L, Brunetti ND. Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients. Heart Fail Rev 2021. [PMID: 34379224 DOI: 10.1007/s10741-021-10157-y] [Reference Citation Analysis]
9 Fang F, Zhang X, Li B, Gan S. miR-182-5p combined with brain-derived neurotrophic factor assists the diagnosis of chronic heart failure and predicts a poor prognosis. J Cardiothorac Surg 2022;17:88. [PMID: 35501813 DOI: 10.1186/s13019-022-01802-0] [Reference Citation Analysis]
10 Palazzuoli A, Caravita S, Paolillo S, Ghio S, Tocchetti CG, Ruocco G, Correale M, Ambrosio G, Perrone Filardi P, Senni M; Italian Society of Cardiology Heart Failure Study Group. Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes. Prog Cardiovasc Dis 2021;67:89-97. [PMID: 33839166 DOI: 10.1016/j.pcad.2021.03.007] [Reference Citation Analysis]
11 Rizzo C, Carbonara R, Ruggieri R, Passantino A, Scrutinio D. Iron Deficiency: A New Target for Patients With Heart Failure. Front Cardiovasc Med 2021;8:709872. [PMID: 34447793 DOI: 10.3389/fcvm.2021.709872] [Reference Citation Analysis]
12 Martín-Sánchez FJ. Comprehensive heart failure assessment: A challenge to modify the course of heart failure. Eur J Intern Med 2020;71:8-10. [PMID: 31812537 DOI: 10.1016/j.ejim.2019.11.013] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Duraes AR, da Silva WAP, Filho CRH, de Souza Lima Bitar Y, Neto MG. Heart Failure and Comorbidities—Part 2. Curr Emerg Hosp Med Rep 2020;8:69-75. [DOI: 10.1007/s40138-020-00211-8] [Reference Citation Analysis]
14 Correale M, Tricarico L, Fortunato M, Mazzeo P, Nodari S, Di Biase M, Brunetti ND. New Targets in Heart Failure Drug Therapy. Front Cardiovasc Med 2021;8:665797. [PMID: 34026873 DOI: 10.3389/fcvm.2021.665797] [Reference Citation Analysis]